IRG is the Initial Review Group of scientists who perform the first
(hence "initial") review for scientific merit in NIH's 2-step review
process. After the IRG finishes, a national research council (there's
one of these for each NIH institute) performs the second stage of the
review. The message means that the proposal is queued up to go to the
first stage of review.
This is the forum where all of us can ask dumb questions, and that's one
of its most valuable features, so keep asking.
PJD
Peter J. Dolce, Ph.D.
Associate Vice President for Research
Meharry Medical College
West Basic Sciences Center
1023 21st Avenue North
Nashville, TN 37208
Phone 615 327 6237
Fax 615 327 6144
-----Original Message-----
From: Research Administration List [mailto:xxxxxx@hrinet.org] On
Behalf Of Watercutter, Rebecca
Sent: Tuesday, July 21, 2009 10:54 AM
To: xxxxxx@hrinet.org
Subject: Re: [RESADM-L] challenge grants
OK. I know this makes me look really dumb, but what does it mean when
status reads: Pending IRG review?
-----Original Message-----
From: Research Administration List [mailto:xxxxxx@hrinet.org] On
Behalf Of Jon Teuber
Sent: Monday, July 20, 2009 10:43 AM
To: xxxxxx@hrinet.org
Subject: Re: [RESADM-L] challenge grants
They are definitely holding these proposals to the limitations posted.
One of
our PIs received a letter saying his proposal was removed because he had
over 10 references. We checked and double checked, and appealed because
both the PI and co-PI had exactly 10 each.
On appeal, NIH responded that their first finding was incorrect, and
that
instead the PI had over one page of references (also a limit)... that
error
finding was valid.
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================
DISCLAIMER: This email and any files transmitted with it may be privileged, confidential, and contain health information that is legally protected. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless permitted to do so by law or regulation. If you are not the intended recipient, you are hereby notified that any use, disclosure, copying, or distribution, is strictly prohibited. If you have received this information in error, please notify the sender immediately and arrange for the return or destruction of these documents.
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================
